ABT vs RCKY · P/E 25, rev $44.33B vs P/E 16, rev $242.8M
Abbott Laboratories (ABT) versus Rocky Brands Inc (RCKY) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Rocky Brands Inc (RCKY) is a footwear & accessories company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported RCKY revenue for 2026-06-30 was $242.8M. Net income was $15.1M. Revenue was up 95.2% from 2026-03-31 to 2026-06-30. RCKY currently screens at market cap $301.7M and trailing P/E 16.2.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. RCKY currently screens at market cap $301.7M and trailing P/E 16.2.
Not investment advice. Open the ABT and RCKY stock pages for the full models.
Not investment advice.